Abbott Laboratories is facing thousands of lawsuits over its Similac baby formula products, with families claiming the company’s cow’s milk-based formulas caused necrotizing enterocolitis in premature infants. The similac class action lawsuit situation has grown into one of the largest infant product liability matters in U.S. history.
In 2026, the litigation is at a critical turning point. Bellwether trials are producing real verdicts. Settlement negotiations are active. And families who haven’t yet filed are running out of time.
This article covers who qualifies, what settlement amounts look like, how to file, and what the latest 2026 developments mean for your family.
One number puts it in perspective: over 1,000 individual lawsuits were consolidated into federal MDL 3026 in the Northern District of Illinois, with more cases still being added.
What Is the Similac Class Action Lawsuit?
The Similac class action lawsuit is actually a collection of individual personal injury and wrongful death cases against Abbott Laboratories, consolidated into a federal multi-district litigation known as MDL 3026.
Many people hear “class action” and assume one big group settlement applies to everyone equally. This case works differently. Each family’s lawsuit is individual, meaning your payout depends on your specific child’s injuries, not a flat payment divided among thousands.
The lawsuits allege that Abbott knew, or should have known, that its cow’s milk-based preterm infant formulas, specifically Similac Special Care and Similac NeoSure, significantly raise the risk of NEC in premature babies. They also allege Abbott failed to warn parents, hospitals, and doctors adequately.
| Key Case Facts | Details |
|---|---|
| Case Type | Multi-district litigation (MDL), not traditional class action |
| MDL Number | MDL 3026 |
| Court | U.S. District Court, Northern District of Illinois |
| Presiding Judge | Judge Rebecca Pallmeyer |
| Primary Defendant | Abbott Laboratories |
| Products at Issue | Similac Special Care, Similac NeoSure |
| Core Allegation | Failure to warn about NEC risk in preterm infants |
The distinction between MDL and class action matters enormously for how much money you can receive.
Similac Lawsuit 2026: Where Things Stand Right Now
By 2026, the Similac lawsuit has moved out of the early litigation phase and into active trial territory. That’s a significant shift from where things were in 2023 and 2024.
Bellwether trials, which are test cases designed to give both sides a read on how juries respond to the evidence, are producing mixed but notable results. Some early trials resulted in verdicts favorable to Abbott. Others resulted in substantial plaintiff verdicts reaching into the tens of millions.
Those plaintiff wins matter because they create pressure on Abbott to settle remaining cases rather than risk more large jury awards.
2026 Case Status Summary:
- Bellwether trials ongoing in the Northern District of Illinois
- Settlement discussions reportedly active behind the scenes
- New cases still being added to the MDL docket
- State court cases proceeding independently in Illinois, Missouri, and other states
- Abbott appealing some earlier plaintiff verdicts
Key Takeaway: The litigation is active and moving fast in 2026, which means families who haven’t yet filed should act quickly to avoid being locked out.
The Similac NEC Lawsuit Explained
The Similac NEC lawsuit centers on a devastating intestinal disease called necrotizing enterocolitis, which attacks the intestinal tissue of premature infants. The claim is that Similac formula dramatically increases the risk of this disease developing in premature babies.
Premature babies have underdeveloped guts. Their intestinal lining is fragile and not ready to process the proteins found in cow’s milk-based formulas. Research published in leading pediatric journals has shown that formula-fed preterm infants face a significantly higher risk of developing NEC compared to those fed breast milk.
The lawsuits argue Abbott knew about this research for years. Internal company documents cited in court filings allegedly show awareness of the NEC risk. Despite this, Abbott continued marketing Similac aggressively to NICUs without putting adequate warnings on the label.
| NEC Risk Factor | Breast Milk | Cow’s Milk Formula |
|---|---|---|
| NEC Incidence Rate | Lower | Significantly higher |
| Gut Inflammation Risk | Low | Elevated in preterm infants |
| Recommended by AAP for Preterm Infants | Yes (donor milk alternative) | Not preferred |
The American Academy of Pediatrics has formally recommended human milk over cow’s milk formula for premature infants, citing NEC risk specifically. That recommendation is now central to the legal arguments being made in court.
Abbott Laboratories Baby Formula Lawsuit: The Full Story
Abbott Laboratories is the Chicago-based pharmaceutical and nutrition giant that makes Similac. The company generated billions in revenue from its infant formula division, and Similac products were standard in NICUs across the country.
The lawsuits didn’t emerge out of nowhere. Abbott was already under intense regulatory scrutiny in 2022 when the FDA forced a recall of formula products from its Sturgis, Michigan manufacturing plant after bacterial contamination was linked to infant deaths. That recall caused a nationwide formula shortage.
The NEC litigation predates the recall but gained significant public momentum after 2022. Plaintiff attorneys argue the Sturgis situation revealed a broader pattern of Abbott prioritizing profits over infant safety.
Abbott’s legal defense has argued that the scientific evidence linking its formula to NEC is not conclusive, that doctors and hospitals were responsible for choosing which formula to use, and that the company did provide information about NEC risk to medical professionals.
Abbott’s Core Defense Arguments:
- Scientific causation is disputed
- Hospitals, not Abbott, chose which formula to administer
- NEC has multiple causes unrelated to formula type
- Federal regulations preempt state failure-to-warn claims (this argument has faced significant legal challenges)
The preemption argument, which would have blocked most lawsuits, was rejected by several courts, allowing cases to proceed to trial.
Key Takeaway: Abbott’s primary legal shield, the preemption argument, has largely failed in court, meaning individual cases are proceeding to juries with real verdicts being delivered.
Who Qualifies for the Similac Lawsuit?
You likely qualify for the Similac lawsuit if your premature baby was fed Similac formula in a NICU and later developed necrotizing enterocolitis or died. The eligibility criteria are fairly specific.
This isn’t a lawsuit where buying a product at a grocery store gets you a claim. The cases involve premature infants in hospital neonatal intensive care units who were given cow’s milk-based Similac products and then suffered NEC-related injuries.
Core Eligibility Requirements:
- Your child was born prematurely (typically before 37 weeks gestation)
- Your child was fed Similac Special Care, Similac NeoSure, or another Similac cow’s milk-based formula while in the NICU
- Your child was diagnosed with NEC or died from NEC-related complications
- The NEC diagnosis or death occurred within a reasonable time after formula feeding began
| Eligibility Factor | Qualifies | Does Not Qualify |
|---|---|---|
| Birth Status | Premature (before 37 weeks) | Full-term infant |
| Feeding Location | NICU, hospital setting | Home formula feeding |
| Formula Type | Similac cow’s milk-based | Soy-based formulas |
| Medical Outcome | NEC diagnosis or NEC-related death | No NEC diagnosis |
| Formula Brand | Similac (Abbott) | Enfamil (separate case) |
If your child was full-term, or if the NEC was not connected to formula feeding, your eligibility is weaker. A case evaluation with a personal injury attorney can clarify your specific situation.
Premature Baby Formula Lawsuit: Why Preterm Infants Are the Focus
Premature infants are the center of these lawsuits because their biology makes them uniquely vulnerable to the harms alleged in the litigation. Think of a premature baby’s gut like a house that isn’t finished being built. You can’t put full electrical load through half-installed wiring.
A full-term baby’s intestines have developed the protective mucosal lining and the beneficial bacteria colonies needed to process cow’s milk proteins. A baby born at 28 weeks doesn’t have any of that. Their intestines are literally still developing outside the womb.
When cow’s milk-based formula reaches that underdeveloped gut, research suggests the proteins and inflammatory agents in the formula can trigger an immune response. That response can spiral into NEC, where the intestinal tissue actually dies.
Why Preterm Babies Are More Vulnerable:
- Underdeveloped intestinal lining
- Immature immune system response
- Lack of protective gut bacteria
- Higher inflammatory response to cow’s milk proteins
- Less ability to regulate gut blood flow
Babies born before 32 weeks have the highest NEC risk and represent the majority of plaintiffs in this litigation. The earlier the birth, generally speaking, the more severe the vulnerability and the stronger the legal case.
Necrotizing Enterocolitis Lawsuit: The Medical Condition Behind the Claims
Necrotizing enterocolitis is a severe gastrointestinal disease that causes the intestinal wall tissue to become inflamed and die. It is one of the most serious conditions a premature infant can face in the NICU.
NEC affects approximately 1 in 1,000 live births overall, but the rate climbs dramatically for very premature infants. Among babies born before 28 weeks, NEC affects somewhere between 7% and 15% of those who survive the initial birth period.
The disease can progress rapidly. A baby showing early signs of feeding intolerance on Monday can be in emergency surgery by Wednesday. NEC requires surgical intervention in about 30% of severe cases, and even with surgery, the mortality rate is significant.
| NEC Severity Stage | Symptoms | Medical Intervention |
|---|---|---|
| Stage 1 (Suspected) | Feeding intolerance, mild abdominal distension | Formula feeding stopped, IV nutrition started |
| Stage 2 (Confirmed) | X-ray confirmation of intestinal gas, abdominal rigidity | Antibiotics, close monitoring |
| Stage 3 (Advanced) | Intestinal perforation, severe sepsis | Emergency surgery, bowel resection |
Children who survive NEC often face lifelong consequences. Short bowel syndrome, nutritional malabsorption, and cognitive development issues from prolonged hospitalization are documented outcomes in NEC survivors. These long-term harms factor directly into settlement amounts.
Key Takeaway: NEC is not a minor condition. It’s a life-threatening disease with documented links to cow’s milk formula, and the severity of your child’s NEC diagnosis directly affects the size of your potential settlement.
Similac Lawsuit Settlement Amounts: What Families Are Being Offered
Similac lawsuit settlement amounts vary widely depending on the severity of the NEC injury, whether the child survived, and the strength of the individual case evidence. There is no single flat number.
For cases involving a child who survived NEC and fully recovered, settlements in the range of $500,000 to $1.5 million have been reported in resolved cases. Cases involving serious long-term injuries, like short bowel syndrome requiring permanent IV nutrition, are reaching into the $2 million to $5 million range.
Wrongful death cases, where a premature infant died from NEC, are seeing the highest reported values, with some verdicts and settlements reaching $5 million to $15 million or more.
| Case Type | Estimated Settlement Range |
|---|---|
| NEC diagnosed, full recovery | $500,000 to $1,500,000 |
| NEC with surgical bowel removal | $1,500,000 to $4,000,000 |
| NEC with short bowel syndrome (chronic) | $2,000,000 to $6,000,000 |
| NEC wrongful death | $5,000,000 to $15,000,000+ |
| Economic damages only (no NEC diagnosis) | Limited recovery, case by case |
These are estimates based on reported verdicts and settlements in the MDL. Individual outcomes vary. The numbers above reflect trends, not guarantees.
Similac NEC Settlement 2026: Latest Numbers and Projections
In 2026, the Similac NEC settlement landscape is being shaped by the outcomes of bellwether trials that took place in 2024 and 2025. Those trial results are now the anchor points for settlement negotiations.
A significant plaintiff verdict in a bellwether trial signals to Abbott that continuing to fight all cases individually would be financially catastrophic. Defense verdicts, on the other hand, give Abbott leverage to push settlement values down.
As of 2026, the bellwether trial results have been mixed but generally supportive of plaintiff claims when juries are presented with strong causation evidence. Legal analysts following MDL 3026 suggest a global settlement program is possible within the next 12 to 24 months.
2026 Settlement Projections:
- Global settlement fund, if established, could total in the billions
- Individual case values within a global settlement would follow tiered criteria
- Families with documented NEC diagnoses and NICU formula records are best positioned
- Early filers tend to receive processing priority in structured settlement programs
The pressure on Abbott is real. The company’s litigation reserve figures, disclosed in quarterly financial reports, have grown substantially, signaling internal preparation for significant settlement outflow.
Similac Lawsuit Payout: How Compensation Is Calculated
Similac lawsuit payout amounts are calculated using a combination of factors that personal injury attorneys and courts weigh when valuing each individual case. It’s not arbitrary.
Think of it like calculating the true cost of a car accident, except the “costs” here include a child’s entire future, not just a crumpled bumper. The calculation is deeply personal and fact-specific.
Factors That Increase Payout Value:
- Younger gestational age at birth (more vulnerable)
- More severe NEC diagnosis (Stage 3 vs. Stage 1)
- Bowel surgery and bowel resection performed
- Long-term medical complications documented
- Clear NICU records showing Similac was the specific formula used
- Death of the infant
Factors That Can Reduce Payout Value:
- Incomplete medical records
- Other potential causes of NEC identified in medical chart
- Delayed claim filing
- Inability to prove Similac specifically was administered
| Compensation Category | What It Covers |
|---|---|
| Medical expenses | NICU bills, surgeries, follow-up care, ongoing treatment |
| Future medical costs | Long-term care for chronic NEC complications |
| Pain and suffering | Physical and emotional harm experienced by the child |
| Parental emotional distress | Psychological impact on family members |
| Wrongful death damages | Funeral costs, loss of companionship, parental grief |
| Punitive damages | Possible in cases where Abbott’s conduct is found especially reckless |
Key Takeaway: Payout size is driven by medical severity and documentation quality. Families with complete NICU records and clear NEC diagnoses stand to recover the most.
Abbott Laboratories Settlement 2026: What the Company Is Facing
Abbott Laboratories is one of the largest healthcare companies in the world, with annual revenues exceeding $20 billion. The NEC litigation represents a substantial financial and reputational threat to the company.
Abbott has not collapsed under the pressure. It has resources to fight. But the cost of individual trials, combined with growing plaintiff verdicts, is making a global resolution increasingly attractive from a business standpoint.
In its financial disclosures, Abbott has acknowledged the NEC litigation as a material legal risk. The company has been building litigation reserves. That accounting language translates to: they’re setting money aside to pay settlements.
What Abbott Is Facing in 2026:
- Over 1,000 cases in MDL 3026 alone
- Hundreds of additional state court cases
- Several plaintiff verdicts already on appeal
- Ongoing bellwether trials in federal court
- Potential punitive damages exposure in cases where internal documents show knowledge of NEC risk
- Reputational damage in the pediatric nutrition market
Abbott’s stock price and investor relations team are watching this litigation carefully. Major institutional settlements in product liability cases tend to be announced when defendants reach a tipping point where fighting further is more costly than paying.
Infant Formula NEC Lawsuit Compensation: What You Can Claim
Infant formula NEC lawsuit compensation covers more categories of harm than many families initially realize. The damages aren’t limited to hospital bills.
Your claim can reach back to everything your family experienced from the moment NEC was diagnosed. If your child survived, it can extend forward to everything they will need in the future because of lasting injuries.
Categories of Recoverable Compensation:
- All NICU-related medical bills, including surgery
- Future medical treatment for ongoing NEC complications
- Physical therapy and rehabilitation costs
- Nutritional support costs (IV feeding for short bowel syndrome)
- Parents’ lost wages during hospitalization
- Travel costs for NICU visits from out-of-area families
- Emotional distress and mental health treatment costs
- Pain and suffering of the child
- Loss of normal childhood development and quality of life
- Wrongful death damages if the child did not survive
For families whose children died, compensation includes funeral and burial costs, the emotional and psychological loss experienced by parents and siblings, and in some states, loss of the future relationship with the child.
These claims aren’t about putting a dollar figure on a life. They’re about holding a corporation accountable for documented harm.
How to File a Similac Lawsuit Claim in 2026
Filing a Similac lawsuit claim in 2026 starts with finding a personal injury attorney who handles NEC baby formula cases, not a general practice lawyer. The specifics of MDL procedure and product liability litigation require specialized experience.
The process moves through predictable steps once you hire counsel. Your attorney handles the court filing. You focus on gathering records.
Step-by-Step Filing Process:
- Contact a specialized attorney: Look for law firms with active MDL 3026 cases
- Initial case evaluation: You’ll describe your child’s birth, formula use, and NEC diagnosis
- Medical records collection: Your attorney requests NICU records, hospital charts, NEC diagnosis documentation
- Case filing: Your attorney files your complaint, which gets added to MDL 3026 or a state court docket
- Discovery phase: Both sides exchange evidence, including medical records and expert reports
- Settlement negotiation or trial: Most cases resolve before trial; some proceed to jury verdict
| Filing Step | Who Does It | Typical Timeframe |
|---|---|---|
| Attorney consultation | You | Week 1 |
| Records request | Your attorney | Weeks 2 to 6 |
| Complaint filed | Your attorney | Weeks 4 to 8 |
| Added to MDL docket | Court clerk | Weeks 6 to 10 |
| Discovery begins | Both sides | Months 3 to 12 |
| Resolution (settlement or trial) | Both sides / jury | 1 to 4 years from filing |
Most attorneys handling these cases work on contingency, meaning you pay nothing upfront and they take a percentage of the recovery.
Key Takeaway: Filing a Similac lawsuit claim in 2026 requires a specialized attorney, complete medical records, and prompt action before statute of limitations deadlines expire.
Similac Lawsuit Filing Deadline 2026: Do Not Miss These Dates
The Similac lawsuit filing deadline in 2026 is not a single national date. Deadlines vary by state based on each state’s statute of limitations for personal injury and wrongful death claims.
Missing your deadline means losing your right to sue, permanently. No exceptions. Courts do not extend statutes of limitations for sympathy reasons.
Statute of Limitations by Claim Type:
| State / Claim Type | Typical Time Limit | Notes |
|---|---|---|
| Personal injury (NEC survivor) | 2 to 3 years from discovery | Varies by state |
| Wrongful death | 1 to 3 years from death | Some states are shorter |
| Illinois (MDL home state) | 2 years from injury discovery | Key MDL jurisdiction |
| Missouri | 5 years personal injury, 3 years wrongful death | More time available |
| Texas | 2 years from injury or death | Strict deadline |
| California | 2 years, with discovery rule | Discovery rule can extend |
The “discovery rule” is critical here. In most states, the clock starts when you knew, or reasonably should have known, that the formula caused your child’s NEC. If you only recently learned about the Abbott connection, your deadline may not have started yet.
In 2026, families who received NEC diagnoses in 2023 and 2024 are entering the window where many state deadlines will expire within the next 12 to 24 months. Do not wait.
Similac Lawsuit Evidence Requirements: What You Need to Prove Your Case
Similac lawsuit evidence requirements center on three things: proving your child was premature, proving they were fed Similac formula in the NICU, and proving they developed NEC as a result.
Sounds straightforward. In practice, the challenge is gathering records from hospitals that may not retain records indefinitely, especially for cases that go back several years.
Essential Evidence for Your Case:
- NICU medical records: These confirm gestational age, admission dates, and formula administered
- NEC diagnosis documentation: Radiology reports (specifically X-rays showing pneumatosis intestinalis), surgical notes, pathology reports
- Feeding logs: NICU nursing notes showing specific formula brand and quantity given
- Discharge summary: Documents the full NICU course and diagnoses
- Birth records: Confirm premature birth status
- Medical bills: Document financial damages
- Expert medical testimony: Your attorney retains a pediatric gastroenterologist or neonatologist to testify on causation
The weakest cases are those where NICU records are incomplete or don’t specifically name Similac as the formula used. Hospitals sometimes use institutional contracts and don’t document brand names clearly on every chart entry.
Your attorney can issue legal subpoenas to hospitals to compel record production. Act before records are purged under hospital retention policies.
Similac Lawsuit Update 2026: Recent Verdicts and Developments
The biggest Similac lawsuit update in 2026 is the ongoing progression of bellwether trials and what those results mean for the thousands of families waiting for resolution.
In 2024, Abbott won two early bellwether trials. Those defense verdicts gave the company ammunition to resist high settlement demands. But subsequent trials produced more mixed results, with at least one substantial plaintiff verdict entering the public record.
Key 2026 Developments:
- Additional bellwether trials scheduled throughout 2026 in the Northern District of Illinois
- State court cases in Illinois and Missouri producing independent verdicts
- Abbott’s appeals of plaintiff verdicts working through the Seventh Circuit Court of Appeals
- Plaintiff attorneys’ committee filing motions to strengthen case management orders
- Growing scientific literature supporting the NEC-formula connection being introduced as new trial evidence
The Seventh Circuit’s handling of Abbott’s appeal arguments will be a pivotal development to watch in 2026. If the appellate court rules against Abbott on key legal questions, it could accelerate settlement discussions significantly.
Legal observers note that the longer this litigation continues without a global resolution, the more expensive it becomes for Abbott in legal fees alone, independent of any verdicts.
Similac Lawsuit MDL: How the Multi-District Litigation Works
The Similac lawsuit MDL, officially MDL 3026, is the federal consolidation of all Similac and related cow’s milk infant formula lawsuits filed in federal courts across the country. Understanding how an MDL works explains why your case isn’t moving as fast as you might expect.
An MDL is like a coordinated legal city. Individual cases are the houses. The MDL is the city infrastructure: shared discovery, common pretrial proceedings, and coordinated scheduling. Each house is still owned individually, but everyone benefits from the shared roads.
How MDL 3026 Works:
| MDL Phase | What Happens | Who It Affects |
|---|---|---|
| Consolidation | All federal cases transferred to one court | All plaintiffs who file in federal court |
| Common discovery | Medical studies, Abbott internal documents obtained once for all | All cases benefit |
| Bellwether selection | A sample of cases chosen to go to trial first | Selected plaintiffs go first |
| Bellwether trials | Test cases tried to real juries | Results inform all remaining cases |
| Settlement discussions | Results from bellwethers drive negotiation | All remaining plaintiffs |
| Resolution | Global settlement or continued individual trials | All plaintiffs |
One key point: filing in state court is also an option. Some plaintiff attorneys prefer state courts in jurisdictions with plaintiff-friendly jury pools. Your attorney advises which venue is stronger for your specific facts.
Key Takeaway: MDL 3026 is designed to make litigation efficient for thousands of plaintiffs at once, but individual families still have their own cases with their own potential recoveries.
Similac Wrongful Death Lawsuit: When a Baby Did Not Survive
The Similac wrongful death lawsuit represents the most heartbreaking category of cases in this litigation. These are families whose premature infants developed NEC and did not survive.
NEC kills. Among very premature infants who develop advanced NEC requiring surgery, mortality rates range from 20% to 50% depending on severity and gestational age. These deaths have fueled some of the most significant verdicts in the litigation.
Wrongful death claims allow parents and, in some states, siblings to recover damages that go beyond what a personal injury claim covers.
Wrongful Death Damages in Similac Cases:
- Funeral and burial expenses
- Medical costs incurred before death
- Parental grief and loss of companionship
- Loss of the parent-child relationship
- Emotional distress experienced by surviving family members
- Punitive damages in cases of especially reckless conduct
| Wrongful Death Element | Who Can Claim | States Vary |
|---|---|---|
| Funeral costs | Parents | Most states |
| Loss of companionship | Parents, sometimes siblings | State-specific |
| Parental grief / mental anguish | Parents | Most states |
| Punitive damages | Estate / parents | Where conduct was reckless |
Wrongful death cases in this litigation have produced some of the largest verdicts. Juries respond to the reality of a premature baby dying in a NICU because a corporation failed to put a clear warning on a formula container.
Families who lost infants to NEC more than two years ago need to check their state’s wrongful death statute immediately. Some states have strict one to two year limitations that may be expiring now.
Frequently Asked Questions
What is the Similac class action lawsuit about?
The Similac class action lawsuit involves claims that Abbott Laboratories failed to warn parents and doctors that its cow’s milk-based Similac formulas increase the risk of necrotizing enterocolitis in premature infants.
The cases are consolidated in federal MDL 3026 in the Northern District of Illinois.
Families of premature babies who developed NEC after being fed Similac in the NICU are the primary plaintiffs.
How much money can families get from the Similac lawsuit settlement?
Settlement amounts range from approximately $500,000 for NEC cases with full recovery to $15 million or more for wrongful death cases.
The exact amount depends on the severity of NEC, whether surgery was required, long-term complications, and the quality of medical records.
Cases involving infant death or permanent disability tend to receive the highest compensation values.
Who qualifies to file a Similac NEC lawsuit?
You qualify if your premature baby was fed Similac cow’s milk-based formula in a NICU and was later diagnosed with necrotizing enterocolitis.
The child must have been born prematurely, typically before 37 weeks gestation.
Families whose infants died from NEC can file wrongful death claims instead of personal injury claims.
What is the filing deadline for the Similac lawsuit in 2026?
There is no single national deadline. Each state has its own statute of limitations, typically ranging from one to three years from the date of injury or discovery.
In Illinois, where the MDL is located, the personal injury statute of limitations is two years.
Families whose children were diagnosed with NEC in 2023 or 2024 may be approaching their deadline right now.
How long does it take to receive a Similac lawsuit settlement payout?
Most NEC lawsuits that settle take one to four years from the filing date to reach final resolution and payment.
Cases that proceed to trial can take longer, while cases in an MDL global settlement program may move faster once a master settlement is established.
Your attorney can give you a realistic timeline based on where your case sits in the MDL process.
What Families Should Do Right Now
The Similac lawsuit is not winding down in 2026. It’s entering a decisive phase where settlements are being negotiated and deadlines are arriving faster than many families realize.
If your premature baby was fed Similac in the NICU and developed NEC, your window to file may be closing. The statute of limitations doesn’t care about grief or how long it took to connect the dots. It only cares about the date.
Gather every piece of NICU paperwork you still have. Birth records, discharge summaries, formula feeding logs, surgical reports. Contact a personal injury attorney who handles MDL 3026 cases. The initial consultation is free, and most attorneys work on contingency.
Your family’s story matters. The legal system exists to hold companies accountable when their products hurt children. Use it.
